Edwards Lifesciences Jumps After FDA Approves Heart Valve
Shares of Edwards Lifesciences Corp. jumped after U.S. regulators approved a newer, thinner version of the company’s artificial heart valve.
The stock rose 2.9 percent to $141.96 at 3:43 p.m. in New York. The shares had risen 8.3 percent this year through Tuesday.
